Showing 1 - 3 of 3 Research Library Publications
Posted: | Victoria Yaneva, Peter Baldwin, Daniel P. Jurich, Kimberly Swygert, Brian E. Clauser

Academic Medicine: Volume 99 - Issue 2 - p 192-197

 

This report investigates the potential of artificial intelligence (AI) agents, exemplified by ChatGPT, to perform on the United States Medical Licensing Examination (USMLE), following reports of its successful performance on sample items. 

Posted: | S. H. Felgoise, R. A. Feinberg, H. B. Stephens, P. Barkhaus, K. Boylan, J. Caress, Z. Simmons

Muscle Nerve, 58: 646-654

 

The Amyotrophic Lateral Sclerosis (ALS)‐Specific Quality of Life instrument and its revised version (ALSSQOL and ALSSQOL‐R) have strong psychometric properties, and have demonstrated research and clinical utility. This study aimed to develop a short form (ALSSQOL‐SF) suitable for limited clinic time and patient stamina.

Posted: | M. C. Edwards, A. Slagle, J. D. Rubright, R. J. Wirth

Qual Life Res 27, 1711–1720 (2018)

 

The US Food and Drug Administration (FDA), as part of its regulatory mission, is charged with determining whether a clinical outcome assessment (COA) is “fit for purpose” when used in clinical trials to support drug approval and product labeling. This paper provides a review (and some commentary) on the current state of affairs in COA development/evaluation/use with a focus on one aspect: How do you know you are measuring the right thing? In the psychometric literature, this concept is referred to broadly as validity and has itself evolved over many years of research and application.